8-K Announcements
6Material company update
May 5, 2026·SEC
Material company update
Mar 17, 2026·SEC
Material company update
Feb 10, 2026·SEC
Hinge Health, Inc.(HNGE)Earnings, Financials & Key Ratios
HNGE•NYSE
Price updated Jun 11, 2026
AboutHinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.Show more
- Revenue$588M+50.6%
- EBITDA-$541M-2828.9%
- Net Income-$528M-4326.9%
- EPS (Diluted)-5.19-3360.0%
- Gross Margin79.65%+3.4%
- EBITDA Margin-92.07%-1845.1%
- Operating Margin-92.94%-1385.3%
- Net Margin-89.86%-2839.9%
- ROE-132.86%-4598.2%
- ROIC-268.21%-2352.3%
- Debt/Equity0.02-20.1%
HNGE Key Insights
Hinge Health, Inc. (HNGE) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓FCF machine: 29.0% free cash flow margin
- ✓Momentum leader: RS Rating 91 (top 9%)
- ✓Trading near 52-week high
✗Weaknesses
- ✗Expensive at 14.0x book value
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when HNGE posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
HNGE Price & Volume
Hinge Health, Inc. (HNGE) stock price & volume — 10-year historical chart
Loading chart...
HNGE Growth Metrics
Hinge Health, Inc. (HNGE) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-
Return on Capital
10 Years-56.99%
5 Years-56.99%
3 Years-56.99%
Last Year-135.52%
HNGE Recent Earnings
Hinge Health, Inc. (HNGE) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 4/5 qtrs (100%)●Beat Revenue 3/5 qtrs (75%)
Q2 2026Latest
May 5, 2026EPS
$0.45
Est $0.39
+15.4%
Revenue
$182M
Est $172M
+5.9%
Q1 2026
Feb 10, 2026EPS
$0.49
Est $0.04
+1125.0%
Revenue
$171M
Est $157M
+9.0%
Q4 2025
Nov 4, 2025EPS
$0.34
Est $0.24
+41.7%
Revenue
$154M
Est $157M
-1.6%
Q3 2025
Aug 5, 2025EPS
$0.67
Est $0.09
+644.4%
Revenue
$139M
Est $132M
+5.1%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $0.45vs $0.39+15.4% | $182Mvs $172M+5.9% |
| Q1 2026 | Feb 10, 2026 | $0.49vs $0.04+1125.0% | $171Mvs $157M+9.0% |
| Q4 2025 | Nov 4, 2025 | $0.34vs $0.24+41.7% | $154Mvs $157M-1.6% |
| Q3 2025 | Aug 5, 2025 | $0.67vs $0.09+644.4% | $139Mvs $132M+5.1% |
Based on last 5 quarters of dataView full earnings history →
HNGE Peer Comparison
Hinge Health, Inc. (HNGE) competitors in Virtual Care and Digital Programs — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 OMCL | 1.72B | 37.82 | 853.72 | 6.53% | 1.67% | 1.64% | 0.17 | |
 TDOC | 1.32B | 7.31 | -6.41 | -1.54% | -6.81% | -12.37% | 0.75 | |
 HIMS | 6.34B | 28.87 | 56.61 | 59% | -0.56% | -2.48% | 2.34 | |
 DOCS | 3.74B | 20.02 | 20.43 | 13.05% | 30.4% | 19.36% | 0.01 | |
 AMWL | 153.05M | 9.16 | -1.54 | -1.98% | -48.16% | -33.48% | 0.02 | |
 OPRX | 99.08M | 5.28 | 19.56 | 18.78% | 6.37% | 5.47% | 0.20 | |
 TALK | 872.74M | 5.21 | 130.25 | 22% | 0.49% | 1.03% | ||
 UNH | 368.11B | 405.55 | 30.65 | 11.81% | 2.68% | 11.54% | 0.77 |
Compare HNGE vs Peers
Hinge Health, Inc. (HNGE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
HNGE Income Statement
Hinge Health, Inc. (HNGE) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|
Sales/Revenue | 292.73M | 390.4M | 587.86M | 646.34M |
Revenue Growth % | - | 33.37% | 50.58% | - |
Cost of Goods Sold | 98.55M | 89.81M | 119.64M | 124.12M |
COGS % of Revenue | 33.67% | 23% | 20.35% | - |
Gross Profit | 194.18M▲ 0% | 300.59M▲ 54.8% | 468.22M▲ 55.8% | 522.22M▲ 0% |
Gross Margin % | 66.33% | 77% | 79.65% | 80.8% |
Gross Profit Growth % | - | 54.8% | 55.77% | - |
Operating Expenses | 324.69M | 325.02M | 1.01B | 1.05B |
OpEx % of Revenue | 110.92% | 83.25% | 172.59% | - |
Selling, General & Admin | 214.63M | 227.53M | 646.46M | 674.68M |
SG&A % of Revenue | 73.32% | 58.28% | 109.97% | - |
Research & Development | 110.06M | 97.49M | 368.14M | 374.98M |
R&D % of Revenue | 37.6% | 24.97% | 62.62% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 |
Operating Income | -130.51M▲ 0% | -24.43M▲ 81.3% | -546.37M▼ 2136.6% | -527.44M▲ 0% |
Operating Margin % | -44.59% | -6.26% | -92.94% | -81.6% |
Operating Income Growth % | - | 81.28% | -2136.57% | - |
EBITDA | -124.89M | -18.48M | -541.24M | -523.61M |
EBITDA Margin % | -42.66% | -4.73% | -92.07% | -81.01% |
EBITDA Growth % | - | 85.2% | -2828.94% | - |
D&A (Non-Cash Add-back) | 5.63M | 5.95M | 5.13M | 3.83M |
EBIT | -108.55M | -11.26M | -546.37M | -522.98M |
Net Interest Income | 0 | 0 | 0 | 0 |
Interest Income | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 |
Other Income/Expense | 21.97M | 13.17M | 19.11M | 17.98M |
Pretax Income | -108.55M▲ 0% | -11.26M▲ 89.6% | -527.26M▼ 4584.3% | -509.46M▲ 0% |
Pretax Margin % | -37.08% | -2.88% | -89.69% | -78.82% |
Income Tax | -405K | 677K | 998K | 816K |
Effective Tax Rate % | 0.37% | -6.01% | -0.19% | -0.16% |
Net Income | -108.14M▲ 0% | -11.93M▲ 89.0% | -528.26M▼ 4326.9% | -510.27M▲ 0% |
Net Margin % | -36.94% | -3.06% | -89.86% | -78.95% |
Net Income Growth % | - | 88.97% | -4326.89% | - |
Net Income (Continuing) | -108.14M | -11.93M | -528.26M | -510.27M |
Discontinued Operations | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 |
EPS (Diluted) | -1.39▲ 0% | -0.15▲ 89.2% | -5.19▼ 3360.0% | -6.19▲ 0% |
EPS Growth % | - | 89.21% | -3360% | - |
EPS (Basic) | -1.39 | -0.15 | -5.36 | - |
Diluted Shares Outstanding | 78.02M | 78.02M | 81.7M | 82.39M |
Basic Shares Outstanding | 78.02M | 78.02M | 79.19M | 78.62M |
Dividend Payout Ratio | - | - | - | - |
HNGE Balance Sheet
Hinge Health, Inc. (HNGE) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|
Total Current Assets | 529.88M | 583.45M | 533.9M | 505.55M |
Cash & Short-Term Investments | 423.36M | 466.57M | 363.86M | 317.31M |
Cash Only | 234.95M | 300.79M | 208M | 188.11M |
Short-Term Investments | 188.4M | 165.79M | 155.87M | 129.2M |
Accounts Receivable | 46.56M | 42.49M | 66.06M | 114.92M |
Days Sales Outstanding | 58.06 | 39.73 | 41.02 | 51.82 |
Inventory | 13.29M | 10.87M | 15.64M | 14.17M |
Days Inventory Outstanding | 49.23 | 44.19 | 47.7 | 42.35 |
Other Current Assets | 32.31M | 39.59M | 57.41M | 59.15M |
Total Non-Current Assets | 92.65M | 89.81M | 210.86M | 223.22M |
Property, Plant & Equipment | 22.48M | 16.99M | 17.35M | 17.31M |
Fixed Asset Turnover | 13.02x | 22.98x | 33.88x | 38.51x |
Goodwill | 61.61M | 61.61M | 64.1M | 64.1M |
Intangible Assets | 2.19M | 1.81M | 2.51M | 2.29M |
Long-Term Investments | 0 | 0 | 113.17M | 218.02M |
Other Non-Current Assets | 6.38M | 9.41M | 13.73M | 49.77M |
Total Assets | 622.53M▲ 0% | 673.26M▲ 8.1% | 744.76M▲ 10.6% | 728.77M▲ 0% |
Asset Turnover | 0.47x | 0.58x | 0.79x | 0.88x |
Asset Growth % | - | 8.15% | 10.62% | 12.54% |
Total Current Liabilities | 184.16M | 249.3M | 362.41M | 414.48M |
Accounts Payable | 0 | 0 | 0 | 69.48M |
Days Payables Outstanding | - | - | - | 51.08 |
Short-Term Debt | 0 | 0 | 0 | 4.23M |
Deferred Revenue (Current) | 140.47M | 217.63M | 300.86M | 941.32M |
Other Current Liabilities | 6.37M | 4.16M | 11.46M | 0 |
Current Ratio | 2.88x | 2.34x | 1.47x | 1.22x |
Quick Ratio | 2.81x | 2.30x | 1.43x | 1.19x |
Cash Conversion Cycle | - | - | - | 43.09 |
Total Non-Current Liabilities | 11.1M | 7.26M | 3.82M | 2.73M |
Long-Term Debt | 0 | 0 | 0 | 0 |
Capital Lease Obligations | 11.1M | 7.26M | 3.82M | 17.32M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 |
Total Liabilities | 195.25M | 256.56M | 366.23M | 417.21M |
Total Debt | 15.73M | 11.07M | 8.04M | 6.97M |
Net Debt | -219.22M | -289.71M | -199.96M | -181.14M |
Debt / Equity | 0.04x | 0.03x | 0.02x | 0.02x |
Debt / EBITDA | - | - | - | -0.01x |
Net Debt / EBITDA | - | - | - | 0.35x |
Interest Coverage | - | - | - | - |
Total Equity | 427.28M▲ 0% | 416.7M▼ 2.5% | 378.54M▼ 9.2% | 311.56M▲ 0% |
Equity Growth % | - | -2.48% | -9.16% | -38.16% |
Book Value per Share | 5.48 | 5.34 | 4.63 | 3.78 |
Total Shareholders' Equity | 427.28M | 416.7M | 378.54M | 311.56M |
Common Stock | 0 | 0 | 0 | 0 |
Retained Earnings | -510.8M | -522.74M | -1.05B | -1.02B |
Treasury Stock | 0 | 0 | 0 | 0 |
Accumulated OCI | 60K | 68K | -20K | -348K |
Minority Interest | 0 | 0 | 0 | 0 |
HNGE Cash Flow Statement
Hinge Health, Inc. (HNGE) cash flow — operating, investing & free cash flow history
| Metric | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|
Cash from Operations | -63.91M | 49M | 171.44M | 209.6M |
Operating CF Margin % | -21.83% | 12.55% | 29.16% | - |
Operating CF Growth % | - | 176.67% | 249.87% | 841.44% |
Net Income | -108.14M | -11.93M | -528.26M | -510.27M |
Depreciation & Amortization | 5.63M | 5.95M | 5.49M | 3.86M |
Stock-Based Compensation | 1.65M | 739K | 643.01M | 619.85M |
Deferred Taxes | -473K | -585K | 53K | -3K |
Other Non-Cash Items | 28.02M | 41.33M | 53.16M | 95.84M |
Working Capital Changes | 9.41M | 13.5M | -2.01M | 329K |
Change in Receivables | -23.13M | -1.34M | -26.63M | -41.21M |
Change in Inventory | 10.56M | 608K | -4.76M | -1.38M |
Change in Payables | 0 | -10.97M | 29.41M | 24.94M |
Cash from Investing | 1.5M | 18.31M | -113.76M | -44.35M |
Capital Expenditures | -1.98M | -1.04M | -708K | -3.44M |
CapEx % of Revenue | 0.68% | 0.27% | 0.12% | 0.53% |
Acquisitions | 0 | 0 | -4M | 0 |
Investments | - | - | - | - |
Other Investing | -2.64M | -2.73M | -5.36M | -3.4M |
Cash from Financing | -3M | -2.2M | -150.47M | -267.42M |
Debt Issued (Net) | 0 | 0 | 0 | 0 |
Equity Issued (Net) | 0 | 610K | 200.18M | 95.52M |
Dividends Paid | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | -65.03M | -169.99M |
Other Financing | -3M | -2.81M | -350.64M | -362.94M |
Net Change in Cash | -65.41M▲ 0% | 65.11M▲ 199.5% | -92.79M▼ 242.5% | -102.17M▲ 0% |
Free Cash Flow | -68.52M▲ 0% | 45.23M▲ 166.0% | 170.73M▲ 277.5% | 206.17M▲ 0% |
FCF Margin % | -23.41% | 11.59% | 29.04% | 31.9% |
FCF Growth % | - | 166% | 277.49% | - |
FCF per Share | -0.88 | 0.58 | 2.09 | 2.50 |
FCF Conversion (FCF/Net Income) | 0.59x | -4.11x | -0.32x | -0.40x |
Interest Paid | 0 | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 1.01M |
HNGE Key Ratios
Hinge Health, Inc. (HNGE) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2024 | 2025 | TTM |
|---|---|---|---|
| Return on Equity (ROE) | -2.83% | -132.86% | -138.7% |
| Return on Invested Capital (ROIC) | -10.94% | -268.21% | -258.97% |
| Gross Margin | 77% | 79.65% | 80.8% |
| Net Margin | -3.06% | -89.86% | -78.95% |
| Debt / Equity | 0.03x | 0.02x | 0.02x |
| FCF Conversion | -4.11x | -0.32x | -0.40x |
| Revenue Growth | 33.37% | 50.58% | - |
Related:HNGE Dividend History·HNGE Revenue History·HNGE Price History·HNGE P/E History·HNGE Financial Ratios·HNGE Institutional Holders
HNGE SEC Filings & Documents
Hinge Health, Inc. (HNGE) SEC filings — annual & quarterly reports (10-K, 10-Q)
HNGE Frequently Asked Questions
Hinge Health, Inc. (HNGE) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Hinge Health, Inc. (HNGE) reported $646.3M in revenue for fiscal year 2025. This represents a 121% increase from $292.7M in 2023.
Hinge Health, Inc. (HNGE) grew revenue by 50.6% over the past year. This is strong growth.
Hinge Health, Inc. (HNGE) reported a net loss of $510.3M for fiscal year 2025.
Dividend & Returns
Hinge Health, Inc. (HNGE) has a return on equity (ROE) of -132.9%. Negative ROE indicates the company is unprofitable.
Hinge Health, Inc. (HNGE) generated $206.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.